BOT:ASX
Botanix Pharmaceuticals Ltd
0,019 A$
0,00%
(0,00) 1D
1 հոկ, 16:10:19 GMT+10 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Mkt. cap
47,22 մլն
Avg. vol.
6,30 մլն
Volume
0,00
52-wk high
0,17 A$
52-wk low
0,02 A$
EPS
-0,03 A$
Shares outstanding
2,76 մլրդ
No. of employees
11
Mkt. cap
47,22 մլն
Avg. vol.
6,30 մլն
Volume
0,00
52-wk high
0,17 A$
52-wk low
0,02 A$
EPS
-0,03 A$
Shares outstanding
2,76 մլրդ
No. of employees
11
News stories
From web sources and news partners
Simply Wall Street
·
14 րոպե առաջ
EquipmentShare.com (EQPT) Commits To 1 Gigawatt Of Power Capacity
TradingView
·
45 րոպե առաջ
S&P 500, Nasdaq, Dow Futures Inch Higher As Investors Cheer Cooling Yields — GOOGL, MU, MAT, NVDA In Focus
Yahoo Finance
·
1 ժամ առաջ
Vylor Takes Corteva’s S&P 500 Seat, Twilio Set To Replace Warner Bros. Discovery — Both Stocks Rise After-Hours
Fox Business
·
3 ժամ առաջ
October could be a huge month for the stock market. Here's why.
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd